Reunion Neuroscience
Entry
2022
Hold
2yr
Exit
2024
Who owns Reunion Neuroscience?
Reunion Neuroscience is a Canadian Biotech company, now owned by MPM BioImpact, which acquired it in 2024 from Novo Holdings.
Hand-verified · updated 2026-08-18
Open JSON · CC-BY
Exit Type
Trade Sale
Buyer
MPM BioImpact
Exit Year
2024
More from Novo Holdings Venture Investments
Other portfolio companies in the same fund.
US
Switzerland
SwedenMore PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns Reunion Neuroscience?
Reunion Neuroscience is now owned by MPM BioImpact, which acquired it in 2024 from Novo Holdings.
When did MPM BioImpact acquire Reunion Neuroscience?
MPM BioImpact acquired Reunion Neuroscience in 2024, buying from Novo Holdings.
Who did Reunion Neuroscience sell to?
Novo Holdings sold Reunion Neuroscience to MPM BioImpact in 2024 (Trade Sale).
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue